IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
NCT00368173
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Growth Hormone Insensitivity Syndrome (GHIS)
Laron Syndrome
Interventions
DRUG:
rhIGF-I/rhIGFBP-3
Sponsor
Insmed Incorporated